Literature DB >> 24852925

Extensive cerebral white matter involvement in a patient with NMO spectrum disorder.

Xavier Ayrignac1, Clarisse Carra Dalière2, Elodie Nerrant2, Thierry Vincent2, Jérôme De Seze3, Pierre Labauge2.   

Abstract

Abnormal brain MRI has been described in up to 60% of patients with NMO patients. However, white matter T2 hyperintensities have been rarely observed. We report the case of a 49-year-old woman with long-lasting neuromyelitis optica (NMO) spectrum disorder and diffuse cerebral white matter T2-weighted hyperintensities. Our case suggests that some NMO patients can progressively develop l extensive cerebral involvement.
© The Author(s), 2014.

Entities:  

Keywords:  Devic’s syndrome; Neuromyelitis Optica; white matter disease

Mesh:

Substances:

Year:  2014        PMID: 24852925     DOI: 10.1177/1352458514536253

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  3 in total

1.  A Little-Known Brain Imaging Feature in Neuromyelitis Optica Spectrum Disorder: A Leukodystrophy-Like Pattern.

Authors:  Jun Seok Lee; Moon Kyung Choi; Jae Joon Lee; Hung Youl Seok
Journal:  J Clin Neurol       Date:  2019-03-11       Impact factor: 3.077

2.  Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional study.

Authors:  Xiayin Zhang; Hui Xiao; Chunxin Liu; Lanqin Zhao; Jinghui Wang; Haiquan Li; Ruixin Wang; Yi Zhu; Chuan Chen; Xiaohang Wu; Duoru Lin; Jingqi Wang; Xing Liu; Wei Qiu; Patrick Yu-Wai-Man; Daniel S Ting; Haotian Lin
Journal:  Br J Ophthalmol       Date:  2020-05-19       Impact factor: 4.638

3.  Optical coherence tomography angiography helps distinguish multiple sclerosis from AQP4-IgG-seropositive neuromyelitis optica spectrum disorder.

Authors:  Chunxin Liu; Hui Xiao; Xiayin Zhang; Yipeng Zhao; Rui Li; Xiaonan Zhong; Yuge Wang; Yaqing Shu; Yanyu Chang; Jingqi Wang; Caixia Li; Haotian Lin; Wei Qiu
Journal:  Brain Behav       Date:  2021-03-30       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.